Stock OM OUTSET MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Outset Medical, Inc.

Equities

OM

US6901451079

Real-time Estimate Cboe BZX
Other stock markets
 10:07:54 2024-06-18 EDT 		5-day change 1st Jan Change
3.605 USD -3.09% Intraday chart for Outset Medical, Inc. -13.70% -31.89%
06-12 Transcript : Outset Medical, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM
05-14 Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Transcript : Outset Medical, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM
Outset Medical to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
BU
Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating
MT
Transcript : Outset Medical, Inc., Q1 2024 Earnings Call, May 08, 2024
Outset Medical, Inc. Announces Jean-Olivier Racine Departs as Chief Technology Officer, Effective May 17, 2024
CI
Earnings Flash (OM) OUTSET MEDICAL Reports Q1 Revenue $28.2M, vs. Street Est of $30.3M
MT
Outset Medical Reports First Quarter 2024 Financial Results
BU
Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024
CI
Outset Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Advance in Monday Afternoon Trading
MT
Outset Medical Shares Rise on US FDA 510(k) Clearance for TabloCart With Prefiltration
MT
Outset Medical Shares Rise 56% After FDA Grants Clearance for TabloCart
DJ
Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell
MT
Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
BU
Outset Medical, Inc. Receives FDA 510(K) Clearance for Tablocart with Prefiltration
CI
Outset Medical to Present at Upcoming Investor Conferences
BU
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
AQ
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
BU
Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OM Stock
  4. News Outset Medical, Inc.